Gylna Loko

Fort De France
France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Safety of prostaglandins in the peripartum period in case of sickle-cell disease: A multicenter cohort study.

Safety of prostaglandins in the peripartum period in case of sickle-cell disease: A multicenter cohort study.

Journal: Pregnancy (Hoboken, N.J.)

Published: August 14, 2026

Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.

Cardiopulmonary Hemodynamic Determinants of Long-Term Survival in Sickle Cell Disease: Insights from the ETENDARD Study.

Journal: American journal of respiratory and critical care medicine

Published: September 12, 2025

Sickle Cell Diastolic Cardiomyopathy and Mortality Risk: A Novel Echocardiographic Framework for Prognostic Stratification.

Sickle Cell Diastolic Cardiomyopathy and Mortality Risk: A Novel Echocardiographic Framework for Prognostic Stratification.

Journal: American journal of hematology

Published: June 03, 2025

Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Double-Blind Controlled Randomized Clinical Trial.

Comparison of Prophylactic and Therapeutic Doses of Anticoagulation for Acute Chest Syndrome in Sickle Cell Disease: The TASC Double-Blind Controlled Randomized Clinical Trial.

Journal: American journal of respiratory and critical care medicine

Published: April 10, 2025

High risk of progression for chronic major organ complications of sickle cell disease in adolescents and young adults: A long-term neonatal cohort study.

High risk of progression for chronic major organ complications of sickle cell disease in adolescents and young adults: A long-term neonatal cohort study.

Journal: American journal of hematology

Published: February 19, 2024

Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort-Hydroxyurea (ESCORT-HU) study.

Hydroxyurea is associated with later onset of acute splenic sequestration crisis in sickle cell disease: Lessons from the European Sickle Cell Disease Cohort-Hydroxyurea (ESCORT-HU) study.

Journal: American journal of hematology

Published: November 05, 2023

A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.

A study of 28 pregnant women with sickle cell disease and COVID-19: elevated maternal and fetal morbidity rates.

Journal: Haematologica

Published: April 11, 2023

Impact of prenatal corticosteroid therapy on sickle cell disease in pregnant women.

Impact of prenatal corticosteroid therapy on sickle cell disease in pregnant women.

Journal: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics

Published: December 04, 2022

Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review.

Case Report of Myelodysplastic Syndrome in a Sickle-Cell Disease Patient Treated with Hydroxyurea and Literature Review.

Journal: Biomedicines

Published: November 03, 2022

"Long-term efficacy and safety of L-glutamine in preventing sickle cell disease-related acute complications and hemolysis in pediatric and adult patients-Real-world, observational study".

"Long-term efficacy and safety of L-glutamine in preventing sickle cell disease-related acute complications and hemolysis in pediatric and adult patients-Real-world, observational study".

Journal: European journal of haematology

Published: November 03, 2022

Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients.

Real-World data on efficacy of L-glutamine in preventing sickle cell disease-related complications in pediatric and adult patients.

Journal: Frontiers in medicine

Published: April 29, 2022

Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19: Preliminary evaluation of a novel algorithm.

Blood exchange transfusion with dexamethasone and Tocilizumab for management of hospitalized patients with sickle cell disease and severe COVID-19: Preliminary evaluation of a novel algorithm.

Journal: American journal of hematology

Published: March 19, 2022

Showing 1-12 of 20

Last Updated: 09/26/2026